1. Seasonal influenza activity is currently elevated in most parts of the country, with the southeast, south-central, and west coast areas experiencing the highest levels of activity.
2. The majority of circulating influenza viruses are influenza A, with influenza A(H1N1) being the most frequently reported subtype.
3. Outpatient visits for respiratory illness, including influenza-like illness (ILI), are above the national baseline for the sixth consecutive week.
4. Influenza hospitalizations have increased compared to the previous week.
5. 14 influenza-associated pediatric deaths have been reported during the 2023-2024 season.
6. The percentage of deaths attributed to pneumonia and influenza (P&I) is below the epidemic threshold.
7. Antiviral susceptibility testing shows high levels of resistance to the adamantanes among influenza A viruses.
8. Vaccination remains the best way to protect against influenza, and antiviral drugs are available for treatment.
9. Surveillance data should be interpreted alongside other respiratory virus activity, including COVID-19 and RSV.
10. The CDC provides additional information on influenza surveillance systems, vaccination recommendations, and international influenza surveillance.